دورية أكاديمية
Immune Checkpoint Inhibitor Rechallenge Safety and Efficacy in Stage IV Non-Small Cell Lung Cancer Patients After Immune-Related Adverse Events
| العنوان: | Immune Checkpoint Inhibitor Rechallenge Safety and Efficacy in Stage IV Non-Small Cell Lung Cancer Patients After Immune-Related Adverse Events |
|---|---|
| المؤلفون: | Guo, Mengni, VanderWalde, Ari M., Yu, Xinhua, Vidal, Gregory A., Tian, G. Gary |
| المصدر: | Clinical Lung Cancer ; volume 23, issue 8, page 686-693 ; ISSN 1525-7304 |
| بيانات النشر: | Elsevier BV |
| سنة النشر: | 2022 |
| المجموعة: | ScienceDirect (Elsevier - Open Access Articles via Crossref) |
| مصطلحات موضوعية: | Cancer Research, Pulmonary and Respiratory Medicine, Oncology |
| نوع الوثيقة: | article in journal/newspaper |
| اللغة: | English |
| DOI: | 10.1016/j.cllc.2022.07.015 |
| الإتاحة: | https://doi.org/10.1016/j.cllc.2022.07.015Test https://api.elsevier.com/content/article/PII:S1525730422001668?httpAccept=text/xmlTest https://api.elsevier.com/content/article/PII:S1525730422001668?httpAccept=text/plainTest |
| حقوق: | https://www.elsevier.com/tdm/userlicense/1.0Test/ ; http://creativecommons.org/licenses/by/4.0Test/ |
| رقم الانضمام: | edsbas.4F1FA335 |
| قاعدة البيانات: | BASE |
| DOI: | 10.1016/j.cllc.2022.07.015 |
|---|